贝氏肌营养不良症中的心肌病：概述
Cardiomyopathy in becker muscular dystrophy: Overview.
作者信息
Ho Rady, Nguyen My-Le, Mather Paul
机构信息
Rady Ho, My-Le Nguyen, Paul Mather, Department of Internal Medicine, Thomas Jefferson University Hospital, Philadelphia, PA 19107, United States.
出版信息
World J Cardiol. 2016 Jun 26;8(6):356-61. doi: 10.4330/wjc.v8.i6.356.
Abstract
Becker muscular dystrophy (BMD) is an X-linked recessive disorder involving mutations of the dystrophin gene. Cardiac involvement in BMD has been described and cardiomyopathy represents the number one cause of death in these patients. In this paper, the pathophysiology, clinical evaluations and management of cardiomyopathy in patients with BMD will be discussed.
摘要
贝克尔肌营养不良症（BMD）是一种X连锁隐性疾病，涉及肌营养不良蛋白基因的突变。BMD患者的心脏受累情况已有报道，心肌病是这些患者的首要死因。本文将讨论BMD患者心肌病的病理生理学、临床评估和管理。
相似文献
1
Cardiomyopathy in becker muscular dystrophy: Overview.
World J Cardiol. 2016 Jun 26;8(6):356-61. doi: 10.4330/wjc.v8.i6.356.
2
[Correlation of cardiac muscle involvement and the dystrophin gene abnormality in Becker muscular dystrophy].
Nihon Rinsho. 1997 Dec;55(12):3142-7.
3
Dilated cardiomyopathy and the dystrophin gene: an illustrated review.
Br Heart J. 1994 Oct;72(4):344-8. doi: 10.1136/hrt.72.4.344.
4
Dystrophin-Deficient Cardiomyopathy.
J Am Coll Cardiol. 2016 May 31;67(21):2533-46. doi: 10.1016/j.jacc.2016.02.081.
5
A case report: Becker muscular dystrophy presenting with epilepsy and dysgnosia induced by duplication mutation of Dystrophin gene.
BMC Neurol. 2016 Dec 12;16(1):255. doi: 10.1186/s12883-016-0777-y.
6
Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy.
Circulation. 2005 Nov 1;112(18):2799-804. doi: 10.1161/CIRCULATIONAHA.104.528281. Epub 2005 Oct 24.
7
Molecular analysis of the Duchenne muscular dystrophy gene in patients with Becker muscular dystrophy presenting with dilated cardiomyopathy.
Muscle Nerve. 1993 Nov;16(11):1161-6. doi: 10.1002/mus.880161104.
8
[Specific features of Becker Muscular Dystrophy patients and female carriers of Duchenne Muscular Dystrophy].
Arch Pediatr. 2015 Dec;22(12 Suppl 1):12S31-6. doi: 10.1016/S0929-693X(16)30006-9.
9
Cardiac Involvement in Duchenne Muscular Dystrophy and Related Dystrophinopathies.
Methods Mol Biol. 2018;1687:31-42. doi: 10.1007/978-1-4939-7374-3_3.
10
Molecular basis of hypertrophic and dilated cardiomyopathy.
Tex Heart Inst J. 1994;21(1):6-15.
引用本文的文献
1
Sensitivity of Different Clinical Outcome Measures in Assessing Adults With Becker Muscular Dystrophy: A 3-Year Natural History Study.
Neurology. 2025 Oct 7;105(7):e214071. doi: 10.1212/WNL.0000000000214071. Epub 2025 Sep 5.
2
Ubiquitination-targeted therapies improve BMD iPSC myogenic cell engraftment and dystrophin expression .
Mol Ther Methods Clin Dev. 2025 Jun 16;33(3):101515. doi: 10.1016/j.omtm.2025.101515. eCollection 2025 Sep 11.
3
Characterisation of a large, single-centre cohort of patients with Becker muscular dystrophy to inform standardised care guidelines.
J Neurol. 2025 Jun 7;272(7):448. doi: 10.1007/s00415-025-13126-9.
4
Progressive cardiomyopathy with intercalated disc disorganization in a rat model of Becker dystrophy.
EMBO Rep. 2024 Nov;25(11):4898-4920. doi: 10.1038/s44319-024-00249-9. Epub 2024 Oct 2.
5
Cardiac MRI in Duchenne and Becker Muscular Dystrophy.
Ann Indian Acad Neurol. 2024 Sep 1;27(5):552-557. doi: 10.4103/aian.aian_988_23. Epub 2024 Sep 30.
6
The Importance of a PM&R Consultation for Becker Muscular Dystrophy Patients Admitted with Cardiomyopathy.
Case Rep Cardiol. 2024 Mar 22;2024:3145086. doi: 10.1155/2024/3145086. eCollection 2024.
7
Electrocardiographic Changes in Jordanian Patients With Becker Muscular Dystrophy.
Cureus. 2023 Oct 24;15(10):e47553. doi: 10.7759/cureus.47553. eCollection 2023 Oct.
8
Modeling Reduced Contractility and Stiffness Using iPSC-Derived Cardiomyocytes Generated From Female Becker Muscular Dystrophy Carrier.
JACC Basic Transl Sci. 2023 Feb 8;8(6):599-613. doi: 10.1016/j.jacbts.2022.11.007. eCollection 2023 Jun.
9
Heart Failure as the Initial Clinical Manifestation of Becker Muscular Dystrophy in an Adult.
Tex Heart Inst J. 2022 Nov 1;49(6). doi: 10.14503/THIJ-21-7634.
10
Neuromuscular diseases and their cardiac manifestations under the spectrum of cardiovascular imaging.
Heart Fail Rev. 2022 Nov;27(6):2045-2058. doi: 10.1007/s10741-022-10260-8. Epub 2022 Jul 20.
本文引用的文献
1
Cardiomyopathy in Duchenne Muscular Dystrophy: Current Value of Clinical, Electrophysiological and Imaging Findings in Children and Teenagers.
Klin Padiatr. 2015 Jul;227(4):225-31. doi: 10.1055/s-0034-1398689. Epub 2015 Jun 9.
2
Arrhythmias in the muscular dystrophies.
Card Electrophysiol Clin. 2015 Jun;7(2):303-8. doi: 10.1016/j.ccep.2015.03.011. Epub 2015 Mar 29.
3
Current understanding of molecular pathology and treatment of cardiomyopathy in duchenne muscular dystrophy.
Molecules. 2015 May 15;20(5):8823-55. doi: 10.3390/molecules20058823.
4
Functional correction in mouse models of muscular dystrophy using exon-skipping tricyclo-DNA oligomers.
Nat Med. 2015 Mar;21(3):270-5. doi: 10.1038/nm.3765. Epub 2015 Feb 2.
5
Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: a randomised, double-blind, placebo-controlled trial.
Lancet Neurol. 2015 Feb;14(2):153-61. doi: 10.1016/S1474-4422(14)70318-7. Epub 2014 Dec 30.
6
Evaluation of post-contrast myocardial t1 in duchenne muscular dystrophy using cardiac magnetic resonance imaging.
Pediatr Cardiol. 2015 Jan;36(1):49-56. doi: 10.1007/s00246-014-0963-x. Epub 2014 Jul 29.
7
What Can We Learn From Clinical Trials of Exon Skipping for DMD?
Mol Ther Nucleic Acids. 2014 Mar 11;3(3):e152. doi: 10.1038/mtna.2014.6.
8
Eteplirsen for the treatment of Duchenne muscular dystrophy.
Ann Neurol. 2013 Nov;74(5):637-47. doi: 10.1002/ana.23982. Epub 2013 Sep 10.
9
Proteomic analysis reveals new cardiac-specific dystrophin-associated proteins.
PLoS One. 2012;7(8):e43515. doi: 10.1371/journal.pone.0043515. Epub 2012 Aug 24.
10
Arrhythmias in the muscular dystrophies.
Heart Rhythm. 2012 Nov;9(11):1890-5. doi: 10.1016/j.hrthm.2012.06.038. Epub 2012 Jun 30.
Zotero 插件